The New York Center for Rare Diseases at Montefiore to Partner with GeneDx, PacBio and Google Health to Increase Genomic Testing Options for Bronx Families
BRONX, N.Y., Nov. 8, 2023 /PRNewswire/ -- The New York Center for Rare Diseases (NYCRD) at Montefiore, recognized as a Center of Excellence by the National Organization for Rare Disorders (NORD), is partnering with GeneDx, PacBio and Google Health to deliver genetic diagnoses for Bronx families living with rare diseases. The goal of the new partnership is to help identify the genetic causes of, and best treatments for rare diseases that have remained undiagnosed, despite using today's most advanced tests.
- On average, the search for a rare disease diagnosis takes five to seven years and can be fraught with misdiagnoses.
- The focus of this research project on the Bronx in New York City adds a level of complexity to rare disease diagnostics.
- "Our aim is to illuminate rare disease mysteries and bring answers and hope to families navigating the complexities of a rare disease."
- Together with PacBio and Montefiore, we can help improve equity in genomics resources and help end long diagnostic odysseys for patients."